Skip to content
Just-Evotec Biologics
Just-Evotec BiologicsJust-Evotec Biologics
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News & Insights
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Technological insights
      • Scientific journals
      • Trade journals
      • Interviews
    • Posters
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec
Search:
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News & Insights
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Technological insights
      • Scientific journals
      • Trade journals
      • Interviews
    • Posters
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec

Press

Just – Evotec Biologics Receives Grant To Enable An Antibody Product For The Prevention Of COVID-19

Press ReleaseOctober 19, 2020

Just – Evotec Biologics receives grant for COVID-19 monoclonal antibody optimisation and cell line development from the COVID-19 therapeutics accelerator Grant enables the optimisation of…

Learn more

Just – Evotec Biologics to Produce Monoclonal Antibody Products Against COVID-19 for The Department of Defense

Press ReleaseJuly 22, 2020

Just – Evotec Biologics to provide process development and manufacturing of monoclonal antibody

Learn more

Just – Evotec Biologics Partners with ABL on Development of Broadly Neutralising Antibody Against HIV

Press ReleaseJune 8, 2020

Just – Evotec Biologics to provide process development required for phase I cGMP clinical manufacturing of broadly neutralising antibody against HIV

Learn more

Just – Evotec Biologics to Collaborate with Ology Bioservices on Antibodies against Coronavirus

Press ReleaseApril 30, 2020

Partnership is part of a contract awarded to Ology Bioservices by the Department of Defense to develop and manufacture monoclonal antibodies for treatment and prevention…

Learn more

Just – Evotec Biologics Announces Product Development and Manufacturing Agreement With OncoResponse

Press ReleaseJanuary 16, 2020

Just – Evotec Biologics will apply its fully integrated technology platform in order to accelerate Oncoresponse’s lead product candidate through development and into the clinic

Learn more

Just – Evotec Biologics Initiates Construction of First J.POD® Facility in North America

Press ReleaseJanuary 14, 2020

The J.POD® technology expands Evotec’s capabilities into flexible commercial biologics manufacturing Confirms Evotec’s role as leading external innovator for the integrated outsourcing of drug discovery…

Learn more

Just – Evotec Biologics Enters Into Multi-Year Collaboration With MSD Around Facility of the Future

Press ReleaseJanuary 14, 2020

• MSD to gain access to manufacturing know-how within Just – Evotec Biologics’ J.POD® facility (“Facility of the future”) • Multi-year collaboration in form of…

Learn more

Just – Evotec Biologics & Biocon Biologics sign licensing deal for a biosimilar asset

Press ReleaseOctober 19, 2019

Biocon Biologics in-licenses an early-stage biosimilar asset, will undertake development, manufacturing and commercialisation under its own label. Just – Evotec Biologics has received a license…

Learn more

Evotec completes acquisition of Just Biotherapeutics

Press ReleaseJuly 3, 2019

Acquisition extends Evotec’s multimodality offering, with integrated solutions for small molecules and biologics. Expands Evotec’s US footprint in Seattle and machine learning capabilities. Deal value…

Learn more

Just Biotherapeutics and Teva enter an agreement for the design and development of a high productivity (HP) biomanufacturing process

Press ReleaseJune 28, 2019

Just Biotherapeutics, Inc. (“Just.Bio”), an integrated design company focused on technologies for accelerating the development and manufacture of biotherapeutics, announced today that they have entered…

Learn more

Evotec jump-starts biologics with acquisition of Just Biotherapeutics

Press ReleaseMay 20, 2019

Evotec’s offering of integrated solutions extended to biologics. Addition of longstanding biologics expertise based on key talents, innovative ML (machine learning) driven technologies and sophisticated…

Learn more
←12←
innovation by design
North America
Just – Evotec Biologics, Inc.
401 Terry Avenue
Seattle, WA 98109
+1 206-651-5094
Europe + International
Just – Evotec Biologics
Business Development
info@evotec.eu

Find us on:

Twitter page opens in new windowLinkedin page opens in new windowMail page opens in new window
© 2023 Just – Evotec Biologics
  • Contact
  • Imprint
  • Privacy Policy
  • Legal notice
footer menu
Go to Top
  • Ask an expert
  • Tweet
  • Share
  • Email
  • Scroll to top
  • Ask an expert
  • Twitter
  • Linkedin
  • Email
  • Whatsapp